BRVE — Braveheart Bio, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2131524 ·
Last close
$22.34
Market Cap
—
52W High
$32.00
52W Low
$20.01
ADV30
461,319
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -15,882,000 | -14,988,000 | 126,956,000 | 122,831,000 | 222,862,000 |
| Mar 2026 | 0 | — | -15,049,000 | -14,280,000 | 81,878,000 | 80,576,000 | 160,270,000 |
| Jun 2025 | 0 | — | -27,000 | -381,000 | — | — | — |
| Mar 2025 | 0 | — | -5,000 | -99,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-16,950,000
Investing CF
$8,000
Financing CF
$59,199,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.60
As of
2026-09-13
Balance + Analyst (yfinance extras)
Retained Earnings
$-95,907,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-15,909,000
Pretax Income TTM
$-15,369,000
Interest Exp TTM
—
Analysts
4
Annual Trend (SEC EDGAR, last 1y)
Revenues vs Net Income (last 1y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -4,505,000 | -66,052,000 | 89,350,000 | 155,222,000 | -65,872,000 | -2,014,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.06T | $1184.63 | — |
| JNJ | JOHNSON & JOHNSON | $644.82B | $267.57 | — |
| ABBV | AbbVie Inc. | $465.26B | $263.29 | — |
| MRK | Merck & Co., Inc. | $368.30B | $149.28 | — |
| NVS | NOVARTIS AG | $276.95B | $145.71 | — |
News headlines (Yahoo Finance, 1h cache)
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
2026-09-16 20:30 · Yahoo
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-09-08 20:03 · Yahoo
Braveheart Bio to Participate in Cantor Global Healthcare Conference
2026-09-01 20:30 · Yahoo
Insiders Are Betting Big on These 3 Healthcare Stocks
2026-08-31 17:20 · Yahoo
Jefferies starts biopharma firm Braveheart at Buy after IPO
2026-08-31 11:00 · Yahoo
The Market Barely Knows These 2 IPO Stocks — Goldman Sachs Says ‘Buy’
2026-09-08 18:01 · Yahoo
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
2026-08-31 13:45 · Yahoo
Braveheart Bio (BRVE) Raised $382.5 Million In Its IPO
2026-08-11 20:08 · Yahoo
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
2026-08-07 20:05 · Yahoo
Braveheart Bio Announces Pricing of Upsized Initial Public Offering
2026-08-06 02:33 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.